Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
21 mars 2024 10h31 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
Asia-Pacific Organ Transplant Diagnostics Market Forecast to Reach $3.45 Billion by 2033 - Advancements in Human Leukocyte Antigen (HLA) Typing Tests Present Opportunities
08 mars 2024 09h37 HE
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Organ Transplant Diagnostics Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.In...
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 févr. 2024 19h01 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
U.S. Organ Procurement Organizations are Strong, CMS Rule Threatens Future Success of Donation System
08 févr. 2024 12h18 HE
|
The Association of Organ Procurement Organizations
MCLEAN, Va., Feb. 08, 2024 (GLOBE NEWSWIRE) -- The Association of Organ Procurement Organizations (AOPO) is calling on the Centers for Medicare and Medicaid (CMS) to deliver a plan to stabilize the...
Europe Organ Transplant Diagnostics Market - Comprehensive Analysis and Forecast 2023-2033
30 janv. 2024 04h54 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Europe Organ Transplant Diagnostics Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The Europe...
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
04 janv. 2024 16h40 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 déc. 2023 18h00 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
29 nov. 2023 16h05 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
With 6.00% CAGR, Organ Preservation Market Size Worth $348.02 Million by 2030 | Vantage Market Research
29 nov. 2023 09h19 HE
|
Vantage Market Research
WASHINGTON, Nov. 29, 2023 (GLOBE NEWSWIRE) -- The Global Organ Preservation Market achieved a valuation of $218.36 Million in 2022 and is anticipated to exceed $348.02 Million by 2030, reflecting a...
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
09 nov. 2023 16h01 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results